D-Lactic Acid → HCID 178434168, compound
Reaction equation
[CH3:1][C:2]1[C:6]2[C:7]([CH:26]3[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]3)=[N:8][C:9]3[N:10]([N:11]=[CH:12][C:13]=3[C:14]3[CH:15]=[N:16][C:17]([C:20]4[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=4)=[CH:18][CH:19]=3)[C:5]=2[NH:4][N:3]=1.[C:32](O)(=[O:36])[C@@H:33]([CH3:35])[OH:34].C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C>CN(C=O)C.C(Cl)CCl>[OH:34][C@H:33]([CH3:35])[C:32]([N:29]1[CH2:30][CH2:31][CH:26]([C:7]2[C:6]3[C:2]([CH3:1])=[N:3][NH:4][C:5]=3[N:10]3[N:11]=[CH:12][C:13]([C:14]4[CH:15]=[N:16][C:17]([C:20]5[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=5)=[CH:18][CH:19]=4)=[C:9]3[N:8]=2)[CH2:27][CH2:28]1)=[O:36]Participants
7
Procedure
A mixture of 3-methyl-6-(6-phenylpyridin-3-yl)-4-(piperidin-4-yl)-1H-dipyrazolo[1,5-a:4′,3′-e]pyrimidine (Int-9l, 42 mg, (\10 mmoL), D-(−)-lactic acid (9.3 mg, 0.10 mmoL), EDC (39.4 mg, 0.20 mmoL), HOBt (13.9 mg, 0.10 mmoL) and DIEA (89 μL, 0.51 mmoL) in DMF (4 mL) was stirred at room temperature for 2 hr. Purification with prep-LC provided (R)-2-hydroxy-1-(4-(3-methyl-6-(6-phenylpyridin-3-yl)-1H-dipyrazolo[1,5-a:4′,3′-e]pyrimidin-4-yl)piperidin-1-yl)propan-1-one (30): LCMS tR=3.07 min (10 min run, UV254nm) Mass calculated for, M+481.2, observed LC/MS m/z 482.6 (M+H).
Workup
- customPurification
Sources & evidence
- ORD record
- ord-51795269eeea4b93b2e8ba8023bebf04
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08609675B2
Reaction notes
Loading…